您当前所在的位置:首页 > 产品中心 > 产品信息
TBBz_分子结构_CAS_577779-57-8)
点击图片或这里关闭

TBBz

产品号 T6951 公司名称 Sigma Aldrich
CAS号 577779-57-8 公司网站 http://www.sigmaaldrich.com
分子式 C7H2Br4N2 电 话 1-800-521-8956
分子量 433.72018 传 真
纯 度 ≥98% (HPLC) 电子邮件
保 存 under inert gas Chembase数据库ID: 154004

产品价格信息

请登录

产品别名

标题
TBBz
IUPAC标准名
4,5,6,7-tetrabromo-1H-1,3-benzodiazole
IUPAC传统名
4,5,6,7-tetrabromo-1H-1,3-benzodiazole
别名
4,5,6,7-Tetrabromobenzimidazole

产品登记号

CAS号 577779-57-8
MDL号 MFCD04116202

产品性质

Empirical Formula (Hill Notation) C7H2N2Br4
纯度 ≥98% (HPLC)
外观 powder
溶解度 DMSO: >10 mg/mL at 60 °C, clear
GHS危险品标识 GHS06
GHS警示词 Danger
GHS危险声明 H301-H319
欧盟危险性物质标志 有毒(Toxic) 有毒(Toxic) (T)
MSDS下载 下载链接
个人保护装置 Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
GHS警示性声明 P301 + P310-P305 + P351 + P338
RID/ADR UN 2811 6.1/PG 3
危险公开号 25-36
安全公开号 26-45
保存条件 under inert gas
保存温度 2-8°C
联合国危险货物等级 6.1
联合国危险货物编号 2811
联合国危险货物包装类别(PG) 3
德国WGK号 3

产品详细信息

详细说明 (English)
Biochem/physiol Actions
TBBz is a cell-permeable Casein Kinase-2 (CK2) inhibitor. CK2 inhibitors, 4,5,6,7-tetrabromobenzotriazole (TBBt, Sigma Cat. # T0826) and rabromobenzimidazole (TBBz), the latter of which was shown to discriminate between different molecular forms of CK2 in yeast. TBBt, with a pK(a) ~5, exists in solution at physiological pH almost exclusively (>99%) as the monoanion; whereas TBBz, with a pKa ~9, is predominantly (>95%) in the neutral form, both of obvious relevance to their modes of binding. In vitro, TBBt inhibits different forms of CK2 with Ki values ranging from 80 to 210 nM. TBBz discriminates better between CK2 forms, with Ki values ranging from 70-510 nM. TBBz is more effective than TBBt in inducing apoptosis and to a lesser degree, necrosis in transformed human cell lines. Dvelopment of shRNA strategies for the selective knockdown of the CK2α and CK2α′ isoforms reinforces the foregoing results, indicating that inhibition of CK2 leads to attenuation of proliferation.
详细说明 (简体中文)
Biochem/physiol Actions
TBBz is a cell-permeable Casein Kinase-2 (CK2) inhibitor. CK2 inhibitors, 4,5,6,7-tetrabromobenzotriazole (TBBt, Sigma Cat. # T0826) and rabromobenzimidazole (TBBz), the latter of which was shown to discriminate between different molecular forms of CK2 in yeast. TBBt, with a pK(a) ~5, exists in solution at physiological pH almost exclusively (>99%) as the monoanion; whereas TBBz, with a pKa ~9, is predominantly (>95%) in the neutral form, both of obvious relevance to their modes of binding. In vitro, TBBt inhibits different forms of CK2 with Ki values ranging from 80 to 210 nM. TBBz discriminates better between CK2 forms, with Ki values ranging from 70-510 nM. TBBz is more effective than TBBt in inducing apoptosis and to a lesser degree, necrosis in transformed human cell lines. Dvelopment of shRNA strategies for the selective knockdown of the CK2α and CK2α′ isoforms reinforces the foregoing results, indicating that inhibition of CK2 leads to attenuation of proliferation.

参考文献